Formulation and Delivery - Chemical
Kaustav Chatterjee, PhD (he/him/his)
Postdoctoral Fellow
Merck & Co., Inc.
Rahway, New Jersey, United States
Kaustav Chatterjee, PhD (he/him/his)
Postdoctoral Fellow
Merck & Co., Inc.
Rahway, New Jersey, United States
Ashish Punia, Ph.D.
Principal Scientist
Merck & Co., Inc.
Rahway, New Jersey, United States
Alex Confer, Ph.D.
Senior Scientist
Merck & Co., Inc.
Rahway, New Jersey, United States
Matthew S. Lamm, Ph.D.
Director
Merck & Co., Inc.
Rahway, New Jersey, United States
Figure 1: a. Tri-layer compact tablet consisting of top and bottom layers of 10% w/w plasticizer-HPMC blend which mimics the film coat and middle HPMC layer mimics the placebo ASD core; b. IR Spectrum of HPMC layer of triacetin system under different stressing conditions, dotted lines indicate maximum (10% w/w Triacetin-HPMC) and minimum (neat HPMC) controls; c. LDIR chemical imaging of initial and stressed HPMC layer of triacetin system and d. IR spectra of the HPMC layer of the PEG 3350 system under different stressing conditions.
Figure 2: Polarized light microscopy of solvent-evaporated ASDs of 50% w/w Probucol-VA-64: a. No plasticizer; b. 20% w/w Triacetin; and c. 20% w/w PEG 3350.
Figure 3: a. Tg vs. Triacetin content for various ASD polymers and b. Tg vs. RH% for various ASD polymers.